Diseases, Conditions, Syndromes

Hope for powerful new C diff. treatment

MGB Biopharma, a biopharmaceutical company which has licensed technology from the University of Strathclyde in Glasgow, Scotland, is developing a powerful new antibiotic treatment for resistant infections including the deadly ...

Diseases, Conditions, Syndromes

Hospital cleaning trial cuts infections

A major trial of a bundle of hospital cleaning practices in 11 Australian hospitals has made significant reductions in healthcare associated infections and demonstrated cost-benefits.

Diseases, Conditions, Syndromes

Researchers closer to the super bug puzzle

Infectious diseases specialists from Austin Health are working closely with Microbiologists from the University of Melbourne to understand how Staph is becoming resistant to all antibiotic therapies.

HIV & AIDS

Fecal microbiota tx feasible for recurrent C. difficile in HIV

(HealthDay)—For HIV-infected individuals with recurrent Clostridium difficile infection, fecal microbiota therapy is feasible, according to a letter published in the May 21 issue of the Annals of Internal Medicine.

Medical research

Sticky antibiotic provides glue for successful treatment

Researchers have found how an antibiotic used to treat a debilitating gut infection stays put inside the body giving it time to effectively treat the problem, a discovery that will pave the way for the development of more ...

page 2 from 6